Find latest Myeloma videos · 600+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

2024 ASH Annual Meeting Insights Hub
S

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implications

By 2024 ASH Annual Meeting Insights Hub FEATURING Samer Al Hadidi
By 2024 ASH Annual Meeting Insights Hub FEATURING Samer Al Hadidi
499 views
January 10, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

2024 ASH Annual Meeting Insights Hub: Myeloma Videos

09:20

ASH 2024 Insights: Upfront Use of Anti-CD38 Monoclonal Antibodies in…

2024 ASH Annual Meeting Insights Hub

A. Khan

73 views
04:04

ASH 2024 Insights: Association of Pre-Treatment Biomarkers With Toxi…

2024 ASH Annual Meeting Insights Hub

D. Hansen

42 views
09:18

ASH 2024 Insights: Belamaf Monotherapy in Pts With R/R Light Chain A…

2024 ASH Annual Meeting Insights Hub

E. Kastritis

40 views
View All

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.5K views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

1.0K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

516 views
04:55

ASH 2024 Insights: Dara vs. Len Maintenance in NDMM - Interim Result…

2024 ASH Annual Meeting Insights Hub

U. Shah

257 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.9K views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

809 views
13:28

Debate: Using BCMA CAR-T in Early vs Late Line R/R MM Treatment

Louisville Hematology Highlights

K. Patel, S. Usmani

208 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

391 views
08:58

Transition of Care for Bispecific Antibodies in RRMM: Closing the Ga…

Cleveland Clinic Taussig Cancer Institute

S. Mazzoni

137 views
11:20

Real-World Characteristics and Outcomes in Patients With RRMM Receiv…

Adeel Khan

153 views
09:15

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

187 views
11:17

CAR-T Strategies and Clinical Considerations for R/R MM

Moffitt Cancer Center

K. Patel

172 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

531 views
29:37

Making Sense in R/R Myeloma: Guideline-Based Current Approaches

Saurabh Chhabra

200 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

604 views
19:38

Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist

Total Health

S. Medeiros

308 views
06:06

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

102 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

733 views
16:55

Anti-BMCA Bispecific Antibodies - Independent Symposium at the 10th …

Springer Healthcare IME

S. Usmani

228 views
AUTOPLAY